{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:17:20Z","timestamp":1771654640529,"version":"3.50.1"},"reference-count":93,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3960\/jslrt.18018","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T22:24:49Z","timestamp":1531261489000},"page":"68-86","source":"Crossref","is-referenced-by-count":14,"title":["The histopathology of bone marrow failure in children"],"prefix":"10.3960","volume":"58","author":[{"given":"Hideto","family":"Iwafuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010; 24: 101-122.","DOI":"10.1016\/j.blre.2010.03.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Leguit RJ, Van Den Tweel JG. The pathology of bone marrow failure. Histopathology. 2010; 57: 655-670.","DOI":"10.1111\/j.1365-2559.2010.03612.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Sakaguchi H, Nakanishi K, Kojima S. Inherited bone marrow failure syndromes in 2012. Int J Hematol. 2013; 97: 20-29.","DOI":"10.1007\/s12185-012-1249-9"},{"key":"4","unstructured":"4 Baumann I, Niemeyer CM, Bennett JM. Childhood myelodysplastic syndrome. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed, Lyon, IARC Press. 2017; pp. 116-120."},{"key":"5","unstructured":"5 Baumann I, Niemeyer CM, Bennett JM, <i>et al.<\/i> Childhood myelodysplastic syndrome. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC Press. 2008; pp. 104-107."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Baumann I, F\u00fchrer M, Behrendt S <i>et al.<\/i> Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012; 61: 10-17.","DOI":"10.1111\/j.1365-2559.2011.04156.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Hasegawa D. The current perspective of low-grade myelodysplastic syndrome in children. Int J Hematol. 2016; 103: 360-364.","DOI":"10.1007\/s12185-016-1965-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kardos G, Baumann I, Passmore SJ <i>et al.<\/i> Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood. 2003; 102: 1997-2003.","DOI":"10.1182\/blood-2002-11-3444"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Niemeyer CM, Baumann I. Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology. 2011; 2011: 84-89.","DOI":"10.1182\/asheducation-2011.1.84"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hasegawa D, Chen X, Hirabayashi S <i>et al.<\/i> Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification. Br J Haematol. 2014; 166: 758-766.","DOI":"10.1111\/bjh.12955"},{"key":"11","unstructured":"11 Brunning RD, Bennett JM, Matutes E, <i>et al.<\/i> Myelodysplastic syndrome with multilineage dysplasia. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed, Lyon, IARC Press. 2017; pp. 111-113."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic\/myeloproliferative diseases. Pathobiology. 2007; 74: 97-114.","DOI":"10.1159\/000101709"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Horny HP, Sotlar K, Valent P. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes. Leuk Res. 2007; 31: 1609-1616.","DOI":"10.1016\/j.leukres.2007.05.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Prokocimer M, Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol. 1981; 75: 34-38.","DOI":"10.1093\/ajcp\/75.1.34"},{"key":"15","unstructured":"15 Iemura A, Tsai M, Ando A <i>et al.<\/i> The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol. 1994; 144: 321-328."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Koijima S. Hematopoietic growth factors and marrow stroma in aplastic anemia. Int J Hematol. 1998; 68: 19-28.","DOI":"10.1016\/S0925-5710(98)00028-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Iwasaki T, Murakami M, Sugisaki C <i>et al.<\/i> Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia. Pathol Int. 2008; 58: 353-360.","DOI":"10.1111\/j.1440-1827.2008.02236.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Saft L, Karimi M, Ghaderi M <i>et al.<\/i> p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q). Haematologica. 2014; 99: 1041-1049.","DOI":"10.3324\/haematol.2013.098103"},{"key":"19","unstructured":"19 Ohara A. Japan national registry of aplastic anemia in children 1988-2005: clinical features and prognosis. Japanese J Pediatr Hematol. 2008; 22: 53-62."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia. Haematologica. 2008; 93: 489-492.","DOI":"10.3324\/haematol.12855"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kojima S. Why is the incidence of aplastic anemia higher in Asia? Expert Rev Hematol. 2017; 10: 277-279.","DOI":"10.1080\/17474086.2017.1302797"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Miano M, Dufour C. The diagnosis and treatment of aplastic anemia: a review. Int J Hematol. 2015; 101: 527-535.","DOI":"10.1007\/s12185-015-1787-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Hartung HD, Olson TS, Bessler M. Acquired aplastic anemia in children. Pediatr Clin North Am. 2013; 60: 1311-1336.","DOI":"10.1016\/j.pcl.2013.08.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Timeus F, Crescenzio N, Longoni D <i>et al.<\/i> Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study. PLoS One. 2014; 9: e101948.","DOI":"10.1371\/journal.pone.0101948"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Hama A, Takahashi Y, Muramatsu H <i>et al.<\/i> Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine. Haematologica. 2015; 100: 1426-1433.","DOI":"10.3324\/haematol.2015.128553"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Barone A, Lucarelli A, Onofrillo D <i>et al.<\/i>. Diagnosis and management of acquired aplastic anemia in childhood. Blood Cells Mol Dis. 2015; 55: 40-47.","DOI":"10.1016\/j.bcmd.2015.03.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Keel SB, Scott A, Sanchez-Bonilla M <i>et al.<\/i> Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. Haematologica. 2016; 101: 1343-1350.","DOI":"10.3324\/haematol.2016.149476"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Shimamura A. Aplastic anemia and clonal evolution: germ line and somatic genetics. Hematology. 2016; 2016: 74-82.","DOI":"10.1182\/asheducation-2016.1.74"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Risitano AM, Maciejewski JP, Green S <i>et al.<\/i> In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR \u03b2-CDR3 sequencing. Lancet. 2004; 364: 355-364.","DOI":"10.1016\/S0140-6736(04)16724-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Cha CH, Park CJ, Chi HS <i>et al.<\/i> CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS. Ann Lab Med. 2014; 34: 426-432.","DOI":"10.3343\/alm.2014.34.6.426"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Park SH, Chi HS, Cho YU <i>et al.<\/i> Clinical Relevance of p53 Immunohistochemical Stain in the Differential Diagnosis Between Pediatric Aplastic Anemia and Refractory Cytopenia of Childhood. Ann Lab Med. 2016; 36: 174-176.","DOI":"10.3343\/alm.2016.36.2.174"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Elghetany MT, Vyas S, Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Ann Hematol. 1998; 77: 261-264.","DOI":"10.1007\/s002770050455"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Soulier J. Fanconi Anemia. Hematology. 2011; 2011: 492-497.","DOI":"10.1182\/asheducation-2011.1.492"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kutler DI, Singh B, Satagopan J <i>et al.<\/i> A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003; 101: 1249-1256.","DOI":"10.1182\/blood-2002-07-2170"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Alter BP, Giri N, Savage SA <i>et al.<\/i> Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2018; 103: 30-39.","DOI":"10.3324\/haematol.2017.178111"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res Fundam Mol Mech Mutagen. 2009; 668: 4-10.","DOI":"10.1016\/j.mrfmmm.2009.01.013"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Godley LA. Inherited predisposition to acute myeloid leukemia. Semin Hematol. 2014; 51: 306-321.","DOI":"10.1053\/j.seminhematol.2014.08.001"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet. 2011; 204: 227-244.","DOI":"10.1016\/j.cancergen.2011.04.005"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Hashmi SK, Allen C, Klaassen R <i>et al.<\/i> Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. Clin Genet. 2011; 79: 448-458.","DOI":"10.1111\/j.1399-0004.2010.01468.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Butturini A, Gale RP, Verlander PC <i>et al.<\/i> Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994; 84: 1650-1655.","DOI":"10.1182\/blood.V84.5.1650.1650"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Cioc AM, Wagner JE, MacMillan ML <i>et al.<\/i> Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics. Am J Clin Pathol. 2010; 133: 92-100.","DOI":"10.1309\/AJCP7W9VMJENZOVG"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Yoshimi A, Niemeyer C, Baumann I <i>et al.<\/i> High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood. Br J Haematol. 2013; 160: 109-111.","DOI":"10.1111\/bjh.12083"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Quentin S, Cuccuini W, Ceccaldi R <i>et al.<\/i> Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions. Blood. 2011; 117: e161-e170.","DOI":"10.1182\/blood-2010-09-308726"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ceccaldi R, Parmar K, Mouly E <i>et al.<\/i> Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell. 2012; 11: 36-49.","DOI":"10.1016\/j.stem.2012.05.013"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Al-Rahawan MM, Alter BP, Bryant BJ <i>et al.<\/i> Bone marrow cell cycle markers in inherited bone marrow failure syndromes. Leuk Res. 2008; 32: 1793-1799.","DOI":"10.1016\/j.leukres.2008.05.020"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Kurotaki H, Tsushima Y, Nagai K <i>et al.<\/i> Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. Acta Haematol. 1999; 102: 115-123.","DOI":"10.1159\/000040984"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Dokal I. Dyskeratosis Congenita. Hematology. 2011; 2011: 480-486.","DOI":"10.1182\/asheducation-2011.1.480"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Calado RT, Young NS. Telomere Diseases. N Engl J Med. 2009; 361: 2353-2365.","DOI":"10.1056\/NEJMra0903373"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Revesz T, Fletcher S, al-Gazali LI <i>et al.<\/i> Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet. 1992; 29: 673-675.","DOI":"10.1136\/jmg.29.9.673"},{"key":"50","unstructured":"50 Savage SA, Cook EF, eds. Dyskeratosis congenital and telomere biology disorders: Diagnosis and management guidelines. https:\/\/www.dcoutreach.org\/sites\/default\/files\/DC%20%26%20TBD%20Diagnosis%20And%20Management%20Guidelines.pdf."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Alter BP, Baerlocher GM, Savage SA <i>et al.<\/i> Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood. 2007; 110: 1439-1447.","DOI":"10.1182\/blood-2007-02-075598"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Alter BP, Giri N, Savage SA <i>et al.<\/i> Telomere length in inherited bone marrow failure syndromes. Haematologica. 2015; 100: 49-54.","DOI":"10.3324\/haematol.2014.114389"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Foucar K, Viswanatha DS, Wilson CS. Non-Neoplastic Disorders of Bone Marrow (Atlas of Nontumor Pathology). 1st series. Washington, DC, American Registry of Pathology. 2008; pp. 221-248.","DOI":"10.55418\/9781933477046"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Alter BP, Rosenberg PS, Giri N <i>et al.<\/i> Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica. 2012; 97: 353-359.","DOI":"10.3324\/haematol.2011.055269"},{"key":"55","unstructured":"55 Ortmann CA, Niemeyer CM, Wawer A <i>et al.<\/i> TERC mutations in children with refractory cytopenia. Haematologica. 2006; 91: 707-708."},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Erlacher M, Strahm B. Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood. Front Pediatr. 2015; 3: 64.","DOI":"10.3389\/fped.2015.00064"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Godley LA, Shimamura A. Genetic predisposition to hematologic malignancies: management and surveillance. Blood. 2017; 130: 424-432.","DOI":"10.1182\/blood-2017-02-735290"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Babushok DV, Bessler M, Olson TS. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma. 2016; 57: 520-536.","DOI":"10.3109\/10428194.2015.1115041"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Alter BP, Giri N, Savage SA <i>et al.<\/i> Cancer in dyskeratosis congenita. Blood. 2009; 113: 6549-6557.","DOI":"10.1182\/blood-2008-12-192880"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Yamaguchi H, Sakaguchi H, Yoshida K <i>et al.<\/i> Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan. Int J Hematol. 2015; 102: 544-552.","DOI":"10.1007\/s12185-015-1861-6"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Vlachos A, Ball S, Dahl N <i>et al.<\/i>. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008; 142: 859-876.","DOI":"10.1111\/j.1365-2141.2008.07269.x"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Ruggero D, Shimamura A. Marrow failure: a window into ribosome biology. Blood. 2014; 124: 2784-2792.","DOI":"10.1182\/blood-2014-04-526301"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Vlachos A, Rosenberg PS, Atsidaftos E <i>et al.<\/i> Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood. 2012; 119: 3815-3819.","DOI":"10.1182\/blood-2011-08-375972"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Dong HY, Wilkes S, Yang H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. Am J Surg Pathol. 2011; 35: 723-732.","DOI":"10.1097\/PAS.0b013e31821247a8"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Fuchs DA, McGinn SG, Cantu CL <i>et al.<\/i> Developmental differences in megakaryocyte size in infants and children. Am J Clin Pathol. 2012; 138: 140-145.","DOI":"10.1309\/AJCP4EMTJYA0VGYE"},{"key":"66","unstructured":"66 Rosse C, Kraemer MJ, Dillon TL <i>et al.<\/i> Bone marrow cell populations of normal infants; the predominance of lymphocytes. J Lab Clin Med. 1977; 89: 1225-1240."},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Dutt S, Narla A, Lin K <i>et al.<\/i> Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood. 2011; 117: 2567-2576.","DOI":"10.1182\/blood-2010-07-295238"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Goudarzi KM, Lindstr\u00f6m MS. Role of ribosomal protein mutations in tumor development (Review) [Review]. Int J Oncol. 2016; 48: 1313-1324.","DOI":"10.3892\/ijo.2016.3387"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell. 2009; 16: 369-377.","DOI":"10.1016\/j.ccr.2009.09.024"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Danilova N, Gazda HT. Ribosomopathies: how a common root can cause a tree of pathologies. Dis Model Mech. 2015; 8: 1013-1026.","DOI":"10.1242\/dmm.020529"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Raiser DM, Narla A, Ebert BL. The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders. Leuk Lymphoma. 2014; 55: 491-500.","DOI":"10.3109\/10428194.2013.812786"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 van den Akker M, Dror Y, Odame I. Transient erythroblastopenia of childhood is an underdiagnosed and self-limiting disease. Acta Paediatr. 2014; 103: e288-e294.","DOI":"10.1111\/apa.12634"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73 Lipton JM, Ellis SR. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am. 2009; 23: 261-282.","DOI":"10.1016\/j.hoc.2009.01.004"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Shaw J, Meeder R. Transient erythroblastopenia of childhood in siblings: case report and review of the literature. J Pediatr Hematol Oncol. 2007; 29: 659-660.","DOI":"10.1097\/MPH.0b013e31814684e9"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Foot AB, Potter MN, Ropner JE <i>et al.<\/i> Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow. J Clin Pathol. 1990; 43: 857-859.","DOI":"10.1136\/jcp.43.10.857"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Dickerman JD. Transient erythroblastopenia of childhood presenting with reticulocytosis and erythroid hyperplasia in the bone marrow. Pediatrics. 1981; 67: 562-564.","DOI":"10.1542\/peds.67.4.562"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Myers KC, Davies SM, Shimamura A. Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update. Hematol Oncol Clin North Am. 2013; 27: 117-128, ix.","DOI":"10.1016\/j.hoc.2012.10.003"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Dror Y, Donadieu J, Koglmeier J <i>et al.<\/i> Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011; 1242: 40-55.","DOI":"10.1111\/j.1749-6632.2011.06349.x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Boocock GRB, Morrison JA, Popovic M <i>et al.<\/i> Mutations in SBDS are associated with Shwachman\u2013Diamond syndrome. Nat Genet. 2002; 33: 97-101.","DOI":"10.1038\/ng1062"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80 Aggett PJ, Cavanagh NP, Matthew DJ <i>et al.<\/i> Shwachman\u2019s syndrome. A review of 21 cases. Arch Dis Child. 1980; 55: 331-347.","DOI":"10.1136\/adc.55.5.331"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81 Mack DR, Forstner GG, Wilschanski M <i>et al.<\/i> Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology. 1996; 111: 1593-1602.","DOI":"10.1016\/S0016-5085(96)70022-7"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82 Singh SA, Vlachos A, Morgenstern NJ <i>et al.<\/i> Breast cancer in a case of Shwachman Diamond syndrome. Pediatr Blood Cancer. 2012; 59: 945-946.","DOI":"10.1002\/pbc.24052"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83 Nakaya T, Kurata A, Hashimoto H <i>et al.<\/i> Young-age-onset pancreatoduodenal carcinoma in Shwachman-Diamond syndrome. Pathol Int. 2014; 64: 75-80.","DOI":"10.1111\/pin.12133"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84 Myers KC, Bolyard AA, Otto B <i>et al.<\/i> Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. J Pediatr. 2014; 164: 866-870.","DOI":"10.1016\/j.jpeds.2013.11.039"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85 Dhanraj S, Matveev A, Li H <i>et al.<\/i> Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome. Blood. 2017; 129: 1557-1562.","DOI":"10.1182\/blood-2016-08-735431"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86 Dror Y, Freedman MH. Shwachman-Diamond syndrome: an inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood. 1999; 94: 3048-3054.","DOI":"10.1182\/blood.V94.9.3048"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87 Elghetany MT, Alter BP. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med. 2002; 126: 452-455.","DOI":"10.5858\/2002-126-0452-PPOIBM"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88 Donadieu J, Fenneteau O, Beaupain B <i>et al.<\/i>. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012; 97: 1312-1319.","DOI":"10.3324\/haematol.2011.057489"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89 Elghetany MT, Alter BP. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med. 2002; 126: 452-455.","DOI":"10.5858\/2002-126-0452-PPOIBM"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90 Toiviainen-Salo S, M\u00e4yr\u00e4np\u00e4\u00e4 MK, Durie PR <i>et al.<\/i> Shwachman\u2013Diamond syndrome is associated with low-turnover osteoporosis. Bone. 2007; 41: 965-972.","DOI":"10.1016\/j.bone.2007.08.035"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91 Khincha PP, Savage SA. Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol. 2013; 50: 333-347.","DOI":"10.1053\/j.seminhematol.2013.09.002"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92 Bogliolo M, Surrall\u00e9s J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr Opin Genet Dev. 2015; 33: 32-40.","DOI":"10.1016\/j.gde.2015.07.002"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93 Draptchinskaia N, Gustavsson P, Andersson B <i>et al.<\/i> The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfananaemia. Nat Genet. 1999; 21: 169-175.","DOI":"10.1038\/5951"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/2\/58_18018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T16:56:41Z","timestamp":1693760201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/58\/2\/58_18018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.18018","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}